


Healthcare News Roundup: Oncology
HSMN NewsFeed - 4 Nov 2013
RaySearch Enters into Distribution Agreement with Hitachi Medical Corporation
RaySearch Enters into Distribution Agreement with Hitachi Medical Corporation
HSMN NewsFeed - 28 Oct 2013
Myriad myPlan(TM) Lung Cancer Test Meets Primary Endpoint in Validation Study
Myriad myPlan(TM) Lung Cancer Test Meets Primary Endpoint in Validation Study
HSMN NewsFeed - 25 Oct 2013
Elekta appoints Niklas Savander as its next President and Chief Executive Officer
Elekta appoints Niklas Savander as its next President and Chief Executive Officer
HSMN NewsFeed - 24 Oct 2013
BSD Reports Increasing European Market Penetration by Terumo for MicroThermX(R) Microwave Ablation System
BSD Reports Increasing European Market Penetration by Terumo for MicroThermX(R) Microwave Ablation System
HSMN NewsFeed - 24 Oct 2013
Myriad myRisk(TM) Hereditary Cancer Test Is Highly Accurate in Key Validation Study
Myriad myRisk(TM) Hereditary Cancer Test Is Highly Accurate in Key Validation Study
HSMN NewsFeed - 22 Oct 2013
Elekta declines to continue to participate in linear accelerator bidding process in Brazil
Elekta declines to continue to participate in linear accelerator bidding process in Brazil
HSMN NewsFeed - 22 Oct 2013
BioReference Laboratories, Inc. Sued by Myriad Genetics, Confident in Its Position
BioReference Laboratories, Inc. Sued by Myriad Genetics, Confident in Its Position
HSMN NewsFeed - 16 Oct 2013
G1 Therapeutics Raises $12.5M Series A Financing Led by MedImmune Ventures
G1 Therapeutics Raises $12.5M Series A Financing Led by MedImmune Ventures
HSMN NewsFeed - 15 Oct 2013
Second Draft NICE Guidance for Aggressive non-Hodgkin Lymphoma Treatment, PIXUVRI(R) (pixantrone)
Second Draft NICE Guidance for Aggressive non-Hodgkin Lymphoma Treatment, PIXUVRI(R) (pixantrone)
HSMN NewsFeed - 14 Oct 2013
Myriad's myPath(TM) Melanoma Test is Highly Effective in Verification Study
Myriad's myPath(TM) Melanoma Test is Highly Effective in Verification Study
HSMN NewsFeed - 10 Oct 2013
RaySearch Laboratories: Institut Paoli-Calmettes becomes first RayStation(R) reference clinic in France
RaySearch Laboratories: Institut Paoli-Calmettes becomes first RayStation(R) reference clinic in France
HSMN NewsFeed - 9 Oct 2013
DFINE Announces First Commercial Cases with STAR(TM) Tumor Ablation System in Europe
DFINE Announces First Commercial Cases with STAR(TM) Tumor Ablation System in Europe
HSMN NewsFeed - 8 Oct 2013
MolecularHealth Continues to Grow Management Team with New Chief Commercial Officer
MolecularHealth Continues to Grow Management Team with New Chief Commercial Officer
HSMN NewsFeed - 8 Oct 2013
Molecular Templates Announces $8.5M Series C Financing and $10.6M Grant Funding
Molecular Templates Announces $8.5M Series C Financing and $10.6M Grant Funding
HSMN NewsFeed - 4 Oct 2013
MetaStat's MetaSite Breast(TM) Diagnostic Assay Predicts Metastasis in Breast Cancer Study
MetaStat's MetaSite Breast(TM) Diagnostic Assay Predicts Metastasis in Breast Cancer Study
HSMN NewsFeed - 1 Oct 2013
BioMarker Strategies Names Jerry Parrott President and Chief Executive Officer
BioMarker Strategies Names Jerry Parrott President and Chief Executive Officer
HSMN NewsFeed - 1 Oct 2013
First urine-based cancer mutation monitoring test available from Trovagene
First urine-based cancer mutation monitoring test available from Trovagene
HSMN NewsFeed - 30 Sep 2013
Amgen Presents New Data From Phase 3 Study Of Talimogene Laherparepvec In Patients With Metastatic Melanoma
Amgen Presents New Data From Phase 3 Study Of Talimogene Laherparepvec In Patients With Metastatic Melanoma
HSMN NewsFeed - 23 Sep 2013
Toshiba’s New Aquilion Large Bore Offers Versatility for Radiology and Oncology
Toshiba’s New Aquilion Large Bore Offers Versatility for Radiology and Oncology
HSMN NewsFeed - 22 Sep 2013
Accuray to Showcase Clinical Utilization and Adoption of its Latest Advanced Product Platforms at ASTRO 2013
Accuray to Showcase Clinical Utilization and Adoption of its Latest Advanced Product Platforms at ASTRO 2013
HSMN NewsFeed - 22 Sep 2013
Nucletron, an Elekta Company, Introduces Esteya, Electronic Brachytherapy for Treating Skin Cancer
Nucletron, an Elekta Company, Introduces Esteya, Electronic Brachytherapy for Treating Skin Cancer
HSMN NewsFeed - 18 Sep 2013
Atossa Genetics Signs Distribution Agreement With McKesson Medical-Surgical
Atossa Genetics Signs Distribution Agreement With McKesson Medical-Surgical
HSMN NewsFeed - 18 Sep 2013
Actinium Pharmaceuticals Appoints Corey Sohmer As Vice President Of Finance And Business Development
Actinium Pharmaceuticals Appoints Corey Sohmer As Vice President Of Finance And Business Development
HSMN NewsFeed - 17 Sep 2013
Dendreon Announces Marketing Authorization for PROVENGE(R) in the European Union
Dendreon Announces Marketing Authorization for PROVENGE(R) in the European Union
HSMN NewsFeed - 16 Sep 2013
Surefire Medical's Anti-Reflux Infusion System May Eliminate Coiling, Lower Cost Of Embolization Procedures
Surefire Medical's Anti-Reflux Infusion System May Eliminate Coiling, Lower Cost Of Embolization Procedures
